Transaction · 0001857177-26-000010
KNSAKiniksa Pharmaceuticals International, plc
Moat Ross
Moat Ross, COO, reported a transaction classified as exercise at Kiniksa Pharmaceuticals International, plc involving 16111.000000 shares for an estimated $0.00. Reported holdings after the transaction were 7250.000000 shares. The stored filing text includes a detected 10b5-1 reference.
exerciseSEC transaction code MCOO
- Trade date
- Oct 30, 2026
- Filing date
- Nov 03, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
KNSA price since this filing
Daily closing prices, with the filing date and available return windowsKNSA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -21.6%1w ago -19.4%1d ago +0.0%
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001857177-26-000010 Share Option
- Transaction date
- Oct 30, 2026 Filed Nov 03, 2026, 11:27 PM · 4d delay
- Shares
- 16,111 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 7,250 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction 10b5-1 Detected
Filing-only score
-20 points
Compact filing score computed from stored Form 4 facts. Version v1.
Low filing signal
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
CHIEF OPERATING OFFICER
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 29, 2026.
- F2
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $91.36 to $92.35. The price reported in this column reflects a weighted average sales price. Upon reques…
- F3
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $92.36 to $93.31. The price reported in this column reflects a weighted average sales price. Upon reques…
- F4
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $93.37 to $94.36. The price reported in this column reflects a weighted average sales price. Upon reques…
- F5
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $94.375 to $95.215. The price reported in this column reflects a weighted average sales price. Upon requ…
- F6
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $95.485 to $96.405. The price reported in this column reflects a weighted average sales price. Upon requ…
- F7
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $96.54 to $97.48. The price reported in this column reflects a weighted average sales price. Upon reques…
- F8
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $97.60 to $98.30. The price reported in this column reflects a weighted average sales price. Upon reques…
- F9
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.64 to $91.63. The price reported in this column reflects a weighted average sales price. Upon reques…
- F10
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $91.64 to $92.525. The price reported in this column reflects a weighted average sales price. Upon reque…
- F11
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $92.732 to $93.725. The price reported in this column reflects a weighted average sales price. Upon requ…
- F12
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $93.94 to $94.135. The price reported in this column reflects a weighted average sales price. Upon reque…
- F13
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting comme…
- F14
The option is fully vested and exercisable.
- F15
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting comme…
- F16
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting comme…
- F17
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting comme…
Related transactions
Same SEC filing0 other transactions
Recent company activity
KNSA0 recent txs